Eli Lilly and Company (NYSE:LLY) is one of the best long term growth stocks to buy according to hedge funds. On January 9, Jefferies reaffirmed a Buy rating on Eli Lilly and Company (NYSE:LLY) and set ...
Good afternoon, everybody. I'm Chris Schott at JPMorgan, and it's my pleasure to be hosting this fireside discussion with Dave Ricks, Chairman and CEO of Eli Lilly. Always a highlight of the ...
In an interview with Bloomberg News, Eli Lilly Chief Financial Officer Lucas Montarce said that the Indiana-based pharma giant remains on track for a potential FDA approval of its obesity pill, ...
Retatrutide's recent trial results suggest it may be even better than Eli Lilly's already approved GLP-1 medication, tirzepatide. Besides weight loss, retatrutide helped many people with ...
Here are some of the names making big moves in midday trading. Eli Lilly — Shares of the weight loss drugmaker fell nearly 4% after Reuters reported that a Food and Drug Administration decision on its ...
Eli Lilly leads the weight loss market ahead of Novo Nordisk. Eli Lilly also has a more diversified lineup of products than its peer. Even considering its seemingly more reasonable valuation, Novo ...
Valve isn't done with VR headsets, and its latest one is its most compelling one yet. Here's everything we know about the Steam Frame. It's been years since Valve first launched its in-house VR ...
More than 12 years ago, Steam creator Valve attempted to usurp Microsoft's hold on PC gaming by introducing the first Steam Machine. The reliance on Linux and a loose hold on OEM hardware ...
Eli Lilly (LLY) closed at $1,081.00 in the latest trading session, marking a +1.64% move from the prior day. The stock outpaced the S&P 500's daily gain of 0.16%. Elsewhere, the Dow gained 0.17%, ...
Struggling with debt is all too common — U.S. consumers carried an average balance of $104,755 in June 2025, from mortgage debt to credit card balances, according to credit bureau Experian. If you're ...
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products ...